Specialties

Data suggest that fewer than twenty percent of patients with type 2 diabetes are lowering their risk of heart disease, prompting prominent doctors to demand immediate action. 

The Diabetes UK teams developed eight priority questions and recommendations to improve the quality of life and care of older diabetes patients. 

New studies suggest that moderate to vigorous exercise may delay heart disease in adults between 70-75.  

Consumption of fish oil plus DASH diet is associated with a partial alteration in lipid metabolism and inflammatory mediators in patients with T2D. 

The benefits of mindfulness and acceptance-based interventions in patients with type 2 diabetes.

Data analysis suggests the need to create CVD prediction models specifically focused on the risk factors that affect patients with type 2 diabetes. 

Patients with cardiac implantable electronic devices (CIEDs) who received an SGLT2i had a significantly lower incidence of atrial arrhythmia (AA) compared to placebo. 

DAPA-CKD trial results indicate a significant benefit for SGLT2 inhibitor dapagliflozin in reducing chronic kidney disease progression and mortality caused by kidney failure and cardiovascular disease, regardless of diabetes status. 

Hyperuricemia has been implicated in the development and progression of chronic kidney disease, and the effects of intensive albuminuria lowering may be beneficial. 

Trials tested the hypothesis that treating patients with intensive therapy to target normal glycated hemoglobin A1c levels would positively affect cardiovascular risk.